Epidemic situation |
Levchenko D.A., Arkhangelskaya I.V., Kruglikov V.D., Gaevskaya N.E., Ezhova M.I., Rengach M.V.
Results of monitoring Vibrio cholerae in the Republic of Kalmykia in 2013–2017
|
6-11 |
Original investigations |
Tutelyan А.V., Orlova O.A., Akimkin V.G.
Evaluation of the microbiological efficiency of using pulsed ultraviolet light units in polyclinics
|
12-15 |
Gilmullina F.S., Zagidullina A.I., Rodygina Zh.A.
Able-bodied population’s attitude towards influenza vaccination
|
16-19 |
Bykov I.P., Sergeev A.G., Toporkova M.G., Mishchenko V.A., Zadorozhnaya I.A., Shlykova G.I.
Herd immunity and pathomorphism of tick-borne viral encephalitis under the conditions of a megalopolis
|
20-27 |
Abuova G.N., Pshenichnaya N.Yu., Berdalieva F.A., Khodzhabekov B.K., Ermakova L.A.
Prediction of an outcome in Crimean hemorrhagic fever
|
28-34 |
Khokhlova Z.A., Gileva R.A., Sereda T.V., Zolotukhina L.Yu., Tishkina A.P., Zakharova E.V.
Central nervous system lesions in HIV-infected patients in an epidemiologically unfavorable region
|
35-42 |
Domonova E.A., Silveistrova О.Yu., Goptar I.А., Кuleshov K.V., Nikiforova A.V., Matosova S.V., Shipulina О.Yu.
First data on the prevalence of inherited chromosomally integrated Human betaherpesvirus 6A/B in Russia
|
43-50 |
Amеlina Е.A., Arsеnyеva V.A., Mardanly S.S., Mardanly S.G., Rotanov S.V.
New opportunities to diagnose HHV-8 infection by enzyme immunoassay
|
51-57 |
Zayachnikova T.E., Tolokolnikova E.V., Krasilnikova A.S., Semenenko T.A., Shuvalov A.N., Malinovskaya V.V.
Clinical and laboratory efficacy of recombinant human interferon-α-2b used as part of the combination therapy of congenital pneumonia in premature babies
|
58-66 |
Заметки из практики |
Ulukhanova L.U., Yaraliev M.M., Karnaeva N.S.
Anti-NMDA receptor encephalitis
|
67-70 |
Reviews and lectures |
Lipnitsky A.V., Markin А.M., Sharov T.N., Viktorov D.V., Toporkov А.V.
Clinical and epidemiological analysis of the incidence of histoplasmosis in the world
|
71-76 |
Ponezheva Zh.B., Makashova V.V.
Treatment with the first Russian direct-acting antiviral drug in patients with chronic hepatitis C
|
77-83 |
Exchange of experience |
Rakitianskaya I.A., Riabova T.S., Kalashnikovа A.A.
Use of allokin-alpha in the treatment of chronic herpesvirus infection in adults
|
84-94 |
History of medicine |
Kuziaev R.Z.
Professor V.P. Pervushin is the pioneer of tick-borne encephalitis (on the 150th anniversary of his birth)
|
95-99 |
Anniversaries |
Lyudmila Vladimirovna Feklisova
|
100 |